AI assistant
Sending…
Vaxcyte, Inc. — Director's Dealing 2024
Nov 19, 2024
31100_dirs_2024-11-19_cc58f64f-e3a6-48e2-9cb2-b3b8ca3d7633.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2024-11-18
Reporting Person: PICKERING GRANT (Director, CHIEF EXECUTIVE OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-18 | Common Stock | G | 710 | — | Disposed | 465301 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 137398 | Indirect |
| Common Stock | 137398 | Indirect |
Footnotes
F1: Represents a bona fide gift of the Issuer's Common Stock to a non-profit educational institution made via a donor advised fund.
F2: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
F3: Shares are held directly by a trust for the benefit of the Reporting Person's son.
More from Vaxcyte, Inc.
Regulatory Filings
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 24